Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as integration points for multiple biochemical signals, and thus are involved in a wide variety of cellular processes, such as proliferation, differentiation, transcription regulation and development. This kinase is specifically expressed in a subset of neurons in the nervous system, and is activated by threonine and tyrosine phosphorylation. Targeted deletion of this gene in mice suggests that it may have a role in stress-induced neuronal apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]
MAPK10 (Mitogen-Activated Protein Kinase 10) is a Protein Coding gene. Diseases associated with MAPK10 include Lennox-Gastaut Syndrome and Pertussis. Among its related pathways are GDNF-Family Ligands and Receptor Interactions and Apoptosis Modulation and Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is MAPK8.
MAPKs (mitogen-activated protein kinases) are serine-threonine kinases that regulate a wide variety of cellular functions.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0004672 | protein kinase activity | IEA | -- |
GO:0004674 | protein serine/threonine kinase activity | IEA | -- |
GO:0004705 | JUN kinase activity | TAS,ISS | 8654373 |
GO:0004707 | MAP kinase activity | IEA,IBA | 21873635 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005634 | nucleus | IBA | 21873635 |
GO:0005654 | nucleoplasm | TAS | -- |
GO:0005737 | cytoplasm | IBA,ISS | -- |
GO:0005739 | mitochondrion | ISS | -- |
GO:0005829 | cytosol | TAS | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Activated TLR4 signalling | ||
2 | IL-2 Pathway |
ErbB Family Pathway
.59
ErbB4 Pathway
.59
Prolactin Signaling
.54
Growth Hormone Signaling
.49
IL-2 Pathway
.48
|
UVC-Induced MAPK Signaling
.44
TREM1 Pathway
.43
HMGB1 Pathway
.36
PI3K Signaling in B-Lymphocyte
.35
|
3 | 4-1BB Pathway |
4-1BB Pathway
.54
CD40 Signaling
.54
CD27 Pathway
.48
NF-KappaB Activation by EBV
.42
|
TNFR2 Pathway
.37
PKR Pathway
.36
SUMO Pathway
.30
|
4 | Toll-Like receptor Signaling Pathways |
Mucin expression in CF via TLRs, EGFR signaling pathways
.42
Immune response IL-1 signaling pathway
.41
|
|
5 | GPCR Pathway |
Paxillin Interactions
.73
Ras Pathway
.73
GPCR Pathway
.62
|
Breast Cancer Regulation by Stathmin1
.58
NFAT in Immune Response
.58
Estrogen Pathway
.55
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | IEA | -- |
GO:0000165 | MAPK cascade | IEA | -- |
GO:0000187 | activation of MAPK activity | IEA | -- |
GO:0006468 | protein phosphorylation | IEA,ISS | -- |
GO:0007165 | signal transduction | TAS | 8654373 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
fostamatinib | Approved, Investigational | Pharma | Target, inhibitor | Kinase Inhibitors | 0 | |
Minocycline | Approved, Investigational | Pharma | Target, inhibitor | 229 | ||
Magnesium | Approved, Experimental, Investigational | Pharma | 0 | |||
Anisomycin | Experimental | Pharma | JNK agonist, potent and specific, JNK, SAPK and p38 activator | 0 | ||
(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime | Experimental | Pharma | Target | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
ADP |
|
Agonist, Full agonist, Partial agonist, Gating inhibitor, Antagonist | 58-64-0 |
|
||
c-JUN peptide |
|
610273-01-3 |
|
|
Compound | Action | Cas Number |
---|---|---|
Anisomycin | JNK, SAPK and p38 activator | 22862-76-6 |
CEP 1347 | Inhibitor of JNK signaling | 156177-65-0 |
c-JUN peptide | Peptide inhibitor of JNK/c-Jun interaction | 610273-01-3 |
Compound | Action | Cas Number |
---|---|---|
AEG 3482 | inhibitor of Jun kinase (JNK)-dependent apoptosis | 63735-71-7 |
Anisomycin | JNK agonist, potent and specific | 22862-76-6 |
AS 602801 | Jun Kinase Inhibitor | 848344-36-5 |
AS601245 | c-Jun NH2-terminal protein kinase inhibitor | 345987-15-7 |
BI 78D3 | Competitive JNK inhibitor | 883065-90-5 |
CC-401 | JNK inhibitor,ATP-competitive | 395104-30-0 |
CC-401 hydrochloride | JNK inhibitor | 1438391-30-0 |
CC-930 | JNK inhibitor,potent and selective | 899805-25-5 |
CEP 1347 | JNK inhibitor | 156177-65-0 |
DTP3 | inhibitor of GADD45β/MKK7 complex | |
IQ 3 | 312538-03-7 | |
JIP-1 (153-163) | 438567-88-5 | |
JNK-IN-7 | Selective JNK inhibitor | 1408064-71-0 |
JNK-IN-8 | JNK inhibitor, selective and irreversible | 1410880-22-6 |
PF-03394197(Oclacitinib) | Novel Janus kinase inhibitor | 1208319-26-9 |
SP 600125 | JNK1/2/3 inhibitor | 129-56-6 |
SR 3576 | 1164153-22-3 | |
SU 3327 | 40045-50-9 | |
TCS JNK 5a | JNK2 and JNK3 inhibitor | 312917-14-9 |
TCS JNK 6o | JNK inhibitor | 894804-07-0 |
ExUns: | 1 | ^ | 2 | ^ | 3 | ^ | 4 | ^ | 5a | · | 5b | ^ | 6 | ^ | 7 | ^ | 8a | · | 8b | · | 8c | · | 8d | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12a | · | 12b | ^ | 13 | ^ | 14 | ^ | 15a | · | 15b | ^ | 16 | ^ | 17 | ^ | 18 | ^ | 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
SP2: | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||
SP4: | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
SP5: | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
SP6: | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||
SP7: | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||
SP8: | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
SP9: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP10: | |||||||||||||||||||||||||||||||||||||||||||||||||
SP11: | - |
This gene was present in the common ancestor of animals and fungi.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | MAPK10 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | MAPK10 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | MAPK10 30 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | MAPK10 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | MAPK10 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Mapk10 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Mapk10 30 |
|
||
Chicken (Gallus gallus) |
Aves | MAPK10 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | MAPK10 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | mapk10 30 |
|
||
Str.13873 30 |
|
||||
Zebrafish (Danio rerio) |
Actinopterygii | mapk10 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | bsk 31 32 |
|
OneToMany | |
Worm (Caenorhabditis elegans) |
Secernentea | jnk-1 31 32 |
|
OneToMany | |
F09C12.2 32 |
|
|
|||
Y51B9A.9 32 |
|
|
|||
C49C3.10b 32 |
|
|
|||
C49C3.10a 32 |
|
|
|||
Baker's yeast (Saccharomyces cerevisiae) |
Saccharomycetes | HOG1 31 |
|
OneToMany | |
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 04 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
747293 | Likely Benign: not provided | 86,067,828(-) | G/C | SYNONYMOUS_VARIANT | |
763905 | Likely Benign: not provided | 86,107,241(-) | C/T | SYNONYMOUS_VARIANT,FIVE_PRIME_UTR_VARIANT | |
764533 | Likely Benign: not provided | 86,101,176(-) | T/C | SYNONYMOUS_VARIANT | |
793018 | Likely Benign: not provided | 86,194,378(-) | G/A | SYNONYMOUS_VARIANT,FIVE_PRIME_UTR_VARIANT | |
rs116053658 | Benign/Likely Benign: Epileptic encephalopathy; not provided | 86,064,323(-) | G/A | SYNONYMOUS_VARIANT |
Disorder | Aliases | PubMed IDs |
---|---|---|
lennox-gastaut syndrome |
|
|
pertussis |
|
|
opioid abuse |
|
|
pheochromocytoma |
|
|
alzheimer disease |
|